Rhythmlink International, LLC© designs, manufactures and distributes medical devices and provides custom packaging, private labeling, custom products and contract manufacturing to its customers. Rhythmlink is recognized as a leader within its field at providing the important physical connection between patients and the diagnostic equipment to record or elicit neurophysiologic biopotentials.
Originally founded by neurodiagnostic technicians and engineers in 2002, Rhythmlink strives to provide continuous innovation and superior quality in all of its products. Rhythmlink celebrated ten years in business in July 2012. Based in Columbia, SC, Rhythmlink's advancements and improvements in technology, business development and corporate branding have brought national and international recognition.
Originally founded by neurodiagnostic technicians and engineers in 2002, Rhythmlink strives to provide continuous innovation and superior quality in all of its products. Rhythmlink celebrated ten years in business in July 2012. Based in Columbia, SC, Rhythmlink's advancements and improvements in technology, business development and corporate branding have brought national and international recognition.
Location: United States, South Carolina, Columbia
Employees: 51-200
Phone: (866) 633-3754
Founded date: 2002
Investors 2
| Date | Name | Website |
| 15.05.2023 | Stellus Ca... | stelluscap... |
| - | Graham Par... | grahampart... |
Mentions in press and media 2
| Date | Title | Description |
| 08.03.2024 | Label-Free Detection Market is growing at a CAGR of 14.2% from 2024 to 2030 by Exactitude Consultancy | Label-Free Detection Market The Exactitude Consultancy Label-Free Detection Market Report – Size, Trends, and Forecast 2024-2030 The label-free detection market is driven by increasing demand for drug discovery, diagnostics, and proteomics ... |
| 04.03.2019 | Term Sheet — Monday, March 4 | RIDING INTO THE PUBLIC MARKETS Good morning, Term Sheet readers. Paid Content A.I. is the answer to protecting your enterprise in the cloud From ExtraHop The filing raised questions around the financial health of the company and whether it ... |